Table 4 comparison of pathological characteristics between ovarian cancer patients with or without metabolic syndrome using Chinese Diabetes Society definition
From: Case-control study of metabolic syndrome and ovarian cancer in Chinese population
Variable | MetS (n, %) | Non-MetS (n, %) | P-value |
|---|---|---|---|
Cases | 144 (25.13) | 429(74.87) | Â |
Age(mean ± SD) (years) | 56.02 ± 8.00 | 51.44 ± 9.29 | <0.001 |
Histology | Â | Â | 0.411 |
serous | 100(69.44) | 304(70.86) | Â |
mucous and others | 44(30.56) | 125(29.14) | Â |
Differentiation | Â | Â | <0.001 |
G1-2 | 94(65.28) | 348(81.12) | Â |
G3 | 50(34.72) | 81(18.82) | Â |
FIGO Stage | Â | Â | 0.003 |
I-II | 25 (17.36) | 129(30.07) | Â |
III-IV | 119(82.64) | 300(69.93) | Â |
Lymph nodes metastasis | Â | Â | 0.002 |
No | 111(77.08) | 376(87.65) | Â |
Yes | 33(22.92) | 53(12.35) | Â |